Skip to main content
. 2001 Feb;45(2):517–524. doi: 10.1128/AAC.45.2.517-524.2001

TABLE 6.

Hypericin pharmacokinetic parameter estimatesa

Patient no. Dose (mg/kg) Tmax Cmax AUC (μg/ml × h) Elimination t1/2 (h)b V/F (liter)c CLTB (ml/ min/m2)d
1 0.05 2.6 46.4 1.75 24.1 14.0 4.7
2 0.05 8.1 13.3 1.03 36.8 36.0 7.1
3 0.05 3.7 18.1 1.37 65.7 48.4 5.3
4 0.05 3.1 29.3 2.87 65.8 22.5 2.2
6 0.05 2.7 24.9 1.32 34.8 28.2 4.5
10 0.05 2.2 42.6 1.02 19.3 24.0 8.1
12 0.05 8.7 39.3 0.93 6.3 13.9 8.9
 Mean 4.4 30.6 1.5 36.1 26.7 5.8
 Median 3.1 29.3 1.3 34.8 24.0 5.3
 SD 2.7 12.6 0.7 22.6 12.3 2.3
13 0.10 5.9 42.1 1.82 22.6 109.0 22.8
15 0.10 6.9 69.4 4.86 37.4 71.9 9.8
16 0.10 3.3 30.0 2.64 58.6 112.1 11.9
18 0.10 1.6 118.0 2.99 16.4 44.0 10.5
 Mean 4.4 64.9 3.1 33.8 84.3 13.4
 Median 4.6 55.8 2.8 30.0 90.5 11.2
 SD 2.4 39.1 1.3 18.8 32.5 6.4
a

Tmax, time to Cmax

b

t1/2, half-life. 

c

V/F, volume of distribution/bioavailability. 

d

CLTB, total body clearance.